During the time frame of the study, mice did not exhibit any overt short-term negative health impacts from the shrunken muscle
Treatment plans can be spread over months to manage costs and let your body respond to each procedure
The standard dosing schedule begins at 0.25 mg weekly for four weeks, then increases to 0.5 mg weekly, with potential escalation to 1 mg or 2 mg weekly depending on glycaemic control and tolerability
Semaglutide activates GLP-1 receptors only
Side Effects and Safety Considerations The most common side effects across GLP1/GIP/glucagon agonists include: Nausea, vomiting, or reduced appetite that feels too strong. Diarrhea or constipation
Efficacy of Once-Weekly Semaglutide Versus Placebo as Add-on to Metformin, Sulfonylurea, or Both in Subjects with Type 2 Diabetes (SUSTAIN 2): A Randomized, Double-Blind, Placebo-Controlled, Phase 3a Trial